What’s 2022 Looking Like For Moderna Stock?

Moderna is poised for a solid 2021 as it ramps up sales of its much sought-after Covid-19 vaccine. The company is on track to deliver between 800 million to 1 billion doses of the shot this year and based on its advance purchase agreements, sales for the year could top $19 billion, up from less…

About the Author

has written 23519 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com